Indivior PLC
INDV | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN4HT335 (+1 more)
- LEI:
- 213800V3NCQTY7IED471
- Country:
- United Kingdom
- Address:
- 234 BATH ROAD, SL1 4EE SLOUGH
- Website:
- https://www.indivior.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Indivior PLC is a leading pharmaceutical company that specializes in developing treatments for addiction and related mental health disorders. Founded in 1994, Indivior has since established itself as a global leader in the field of addiction treatment, with a presence in over 40 countries worldwide. The company's products are primarily focused on treating opioid addiction, including the development of innovative medications that help patients manage withdrawal symptoms and reduce the risk of relapse. Indivior's portfolio includes a range of medications, including Suboxone, a prescription medication used to treat opioid dependence, and Perseris, an injectable medication used to treat schizophrenia.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-24 16:52 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.4 KB | |
| 2025-07-24 09:34 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.1 KB | |
| 2025-07-23 09:08 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.1 KB | |
| 2025-07-21 17:23 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.1 KB | |
| 2025-07-21 09:33 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.1 KB | |
| 2025-07-18 09:35 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.2 KB | |
| 2025-07-17 15:00 |
Report Publication Announcement
Notice of Results
|
English | 10.6 KB | |
| 2025-07-01 09:43 |
Major Shareholding Notification
Holding(s) in Company
|
English | 56.2 KB | |
| 2025-07-01 08:49 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 4.8 KB | |
| 2025-06-30 08:00 |
Regulatory News Service
Indivior Announces Inclusion in US Russell Indexes
|
English | 12.9 KB | |
| 2025-06-25 08:00 |
Board/Management Information
Indivior Appoints Tony Kingsley to the Board
|
English | 14.0 KB | |
| 2025-06-17 17:42 |
Major Shareholding Notification
Holding(s) in Company
|
English | 26.7 KB | |
| 2025-06-13 09:10 |
Director's Dealing
Director/PDMR Shareholding - Correction
|
English | 28.2 KB | |
| 2025-06-12 17:24 |
Director's Dealing
Director/PDMR Shareholding
|
English | 26.9 KB | |
| 2025-06-10 17:12 |
Major Shareholding Notification
Holding(s) in Company
|
English | 26.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Financière de Tubize S.A. | Belgium | TUBAT | |
|
Fine Foods & Pharmaceuticals Ntm | Italy | FF | |
|
Flerie AB | Sweden | FLERIE | |
|
Friulchem | Italy | FCM | |
|
FRP ADVISORY GROUP PLC | United Kingdom | FRP | |
|
Fuji Pharma Co.,Ltd. | Japan | 4554 | |
|
FunPep Company Limited | Japan | 4881 | |
|
Fuso Pharmaceutical Industries,Ltd. | Japan | 4538 | |
|
Galderma Group AG | Switzerland | GALD | |
|
GlaxoSmithKline PLC | United Kingdom | GSK |